NEKTAR THERAPEUTICS — Director's Dealing 2015

Jun 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2015-06-19

Reporting Person: CHESS ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-19	Common Stock	M	15000	$8.81	Acquired	275623	Direct
2015-06-19	Common Stock	S	15000	$11.81	Disposed	260623	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-19	Stock Option	$8.81	M	15000	Disposed	2015-09-18	Common Stock (15000)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for stock options expiring in the near term.

F2: This number includes 4,914 shares held by the reporting person in the Issuer's 401(k) plan. The acquisition of these shares under that plan is exempt under Rule 16b-3(c).